• 1
    American College of Rheumatology Committee to Reevaluate Improvement Criteria in Rheumatoid Arthritis. A proposed revision to the ACR20: the hybrid measure of American College of Rheumatology response. Arthritis Rheum 2007; 57: 193202.
  • 2
    Felson DT, Anderson JJ, Boers M, Bombardier C, Chernoff M, Fried B, et al, and the Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. Arthritis Rheum 1993; 36: 72940.
  • 3
    Van der Heijde DM, van 't Hof MA, van Riel PL, Theunisse LA, Lubberts EW, van Leeuwen MA, et al. Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score. Ann Rheum Dis 1990; 49: 91620.
  • 4
    Van Gestel AM, Haagsma CJ, van Riel PL. Validation of rheumatoid arthritis improvement criteria that include simplified joint counts. Arthritis Rheum 1998; 41: 184550.
  • 5
    Grigor C, Capell H, Stirling A, McMahon AD, Lock P, Vallance R, et al. Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomized controlled trial. Lancet 2004; 364: 2639.
  • 6
    Aletaha D, Smolen J. The Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI): a review of their usefulness and validity in rheumatoid arthritis. Clin Exp Rheumatol 2005; 23 Suppl 39: S1008.
  • 7
    Pincus T, Bergman M, Yazici Y, Raghupathi K, Hines P, Maclean R. Rheumatoid Arthritis Patient Index Data (RAPID): performance in two abatacept clinical trials of 4 absolute indices of 2–5 core data set measures based on patient reported outcomes for use in standard clinical care [abstract]. Arthritis Rheum 2006; 54 Suppl 9: S375.